The Paroxysmal Nocturnal Hemoglobinuria treatment market is experiencing significant expansion, driven by increasing disease awareness, rising preval ...

A 2-year-old Georgia boy, Beckham Reed, is currently fighting for his life after being stung 150 times by yellow jackets, ...

Hemoglobin-based blood substitutes are being developed as oxygen-carrying agents for the prevention of ischemic tissue damage and hypovolemic (low blood volume) shock.

Results from the Phase III ZENITH trial show that patients treated with Winrevair (sotatercept-csrk) for pulmonary arterial ...

Accelerated approval was based on results from the Phase I/II LINKER-MM1 trial, which showed a 70% objective response rate in ...

A formulation of MSD's cancer drug Keytruda that can be given by subcutaneous injection rather than intravenous infusion has cleared a phase 3 trial, setting up approvals later this year. The ...

Similarly, cytochrome c, located within the inner membrane of mitochondria, (10) serves a function different from myoglobin and hemoglobin. Instead of carrying oxygen, cytochrome c transports ...

Strategy for change: A CCL for intravenous (IV) high-risk medications and lines was designed to promote safer medication administration at the intensive care unit bedside and in other acute wards.

A novel intravenous iron formulation for the treatment of anaemia in inflammatory bowel disease: the ferric carboxymaltose (FERRINJECT) randomized controlled trial.